A case of juvenile bullous pemphigoid - Successful treatment with diaminodiphenylsulfone and prednisone

Pediatric Dermatology

Volumn 26, Issue 1, 2009, Pages 55-58

  Marcus, Karen A ^a   Halbertsma, Feico J J ^a   Van Steensel, Maurice A M ^b  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; DAPSONE; ESTRADIOL BENZOATE PLUS PROGESTERONE; FUSIDIC ACID; HYDROXYZINE; PREDNISONE;

ARTICLE; BLISTER; CASE REPORT; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; FEMALE; HUMAN; MEDICAL EXAMINATION; PEMPHIGOID; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROLOGY; SKIN BIOPSY; SKIN DISEASE; STAINING; VESICULAR RASH;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PEMPHIGOID, BULLOUS; PREDNISONE;

EID: 60449101298     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00822.x     Document Type: Article

References (24)

1. Dopp R, Schmidt E, Chimanovitch I et al. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 2000 42 : 577 583.
2. Zillikens D, Mascaro JM, Rose PA et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997 109 : 679 683.
3. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991 67 : 869 877.
4. Diaz LA, Ratrie H III., Saunders WS et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 1990 86 : 1088 1094.
5. Delgado JC, Turbay D, Yunis EJ et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 1996 93 : 8569 8571.
6. Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001 44 : 348 350.
7. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol 2002 29 : 781 785.
8. Wang GQ, Xu H, Wang YK et al. Higher prevalence of human herpesvirus 8 DNA sequence and specific IgG antibodies in patients with pemphigus in China. J Am Acad Dermatol 2005 52 : 460 467.
9. Horiguchi Y, Fujii S, Takase S et al. Case of pemphigus vulgaris in oral mucosa showing an extension to the body surface with recurrent varicella. Int J Dermatol 2005 44 : 951 954.
10. Goon AT, Tay YK, Tan SH. Pemphigus vulgaris following varicella infection. Clin Exp Dermatol 2001 26 : 661 663.
11. Bourdon-Lanoy E, Roujeau JC, Joly P et al. Bullous pemphigoid in young patients: a retrospective study of 74 cases. Ann Dermatol Venereol 2005 132 : 115 122.
12. Nemeth AJ, Klein AD, Gould EW et al. Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol 1991 127 : 378 386.
13. Kromminga A, Scheckenbach C, Georgi M et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 2000 15 : 293 300.
14. Martinez-De Pablo MI, Gonzalez-Ensenat MA, Vicente A et al. Childhood bullous pemphigoid: clinical and immunological findings in a series of 4 cases. Arch Dermatol 2007 143 : 215 220.
15. Fisler RE, Saeb M, Liang MG et al. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol 2003 25 : 183 189.
16. Khumalo N, Kirtschig G, Middleton P et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2005 Jul 20 3 CD002292.
17. Joly P, Roujeau JC, Benichou J et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002 346 : 321 327.
18. Wojnarowska F, Kirtschig G, Highet AS et al. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002 147 : 214 221.
19. Motegi S, Abe M, Tamura A et al. Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone. J Dermatol 2005 32 : 809 812.
20. Rzany B, Partscht K, Jung M et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 2002 138 : 903 908.
21. Roujeau JC, Lok C, Bastuji-Garin S et al. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998 134 : 465 469.
22. Ahmed AR, Maize JC, Provost TT. Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol 1977 113 : 1043 1046.
23. Edwards S, Wakelin SH, Wojnarowska F et al. Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children. Pediatr Dermatol 1998 15 : 184 190.
24. Voltan E, Maeda JY, Muniz Silva MA et al. Childhood bullous pemphigoid: report of three cases. J Dermatol 2005 32 : 387 392.